HK1119771A1 - Devices and methods for diagnosing or predicting early stage cardiac dysfunctions - Google Patents

Devices and methods for diagnosing or predicting early stage cardiac dysfunctions

Info

Publication number
HK1119771A1
HK1119771A1 HK08111542.2A HK08111542A HK1119771A1 HK 1119771 A1 HK1119771 A1 HK 1119771A1 HK 08111542 A HK08111542 A HK 08111542A HK 1119771 A1 HK1119771 A1 HK 1119771A1
Authority
HK
Hong Kong
Prior art keywords
devices
methods
diagnosing
early stage
cardiac dysfunctions
Prior art date
Application number
HK08111542.2A
Other languages
English (en)
Inventor
Ildiko Amann-Zalan
Bernhard Trauth
Otero Jose Miguel Rivera
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1119771A1 publication Critical patent/HK1119771A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • External Artificial Organs (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
HK08111542.2A 2005-05-09 2008-10-17 Devices and methods for diagnosing or predicting early stage cardiac dysfunctions HK1119771A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05010043A EP1722232A1 (fr) 2005-05-09 2005-05-09 Dispositifs et procédés de diagnostics ou de prévoir d'un stade précoce des dysfonctionnements cardiaques
PCT/EP2006/062031 WO2006120152A1 (fr) 2005-05-09 2006-05-03 Dispositifs et methodes permettant de diagnostiquer ou de predire des dysfonctionnements cardiaques a un stade precoce

Publications (1)

Publication Number Publication Date
HK1119771A1 true HK1119771A1 (en) 2009-03-13

Family

ID=34936290

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08111542.2A HK1119771A1 (en) 2005-05-09 2008-10-17 Devices and methods for diagnosing or predicting early stage cardiac dysfunctions

Country Status (10)

Country Link
US (1) US20110104813A1 (fr)
EP (2) EP1722232A1 (fr)
JP (1) JP4927825B2 (fr)
CN (2) CN103091497A (fr)
AT (1) ATE482398T1 (fr)
CA (1) CA2605247A1 (fr)
DE (1) DE602006017058D1 (fr)
ES (1) ES2352351T3 (fr)
HK (1) HK1119771A1 (fr)
WO (1) WO2006120152A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1722232A1 (fr) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Dispositifs et procédés de diagnostics ou de prévoir d'un stade précoce des dysfonctionnements cardiaques
HUE025408T2 (hu) 2007-01-25 2016-02-29 Hoffmann La Roche IGFBP-7 alkalmazása szívelégtelenség megítélésében
EP2425016B1 (fr) 2009-04-29 2015-04-01 Academisch Medisch Centrum bij de Universiteit van Amsterdam Moyens et procédés pour contrebalancer, prévenir et/ou déterminer une insuffisance cardiaque, ou un risque d'insuffisance cardiaque
EP2646822B1 (fr) * 2010-11-29 2017-11-01 Alere San Diego, Inc. Procédés pour le diagnostic et la prédiction du risque d'insuffisance cardiaque
JP6298054B2 (ja) 2012-08-09 2018-03-20 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 心不全の診断
CN106716135B (zh) * 2014-10-10 2019-03-15 松森昭 用于检测心力衰竭的装置及储存介质
WO2017210488A1 (fr) * 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Dosage protéolytique du peptide natriurétique de type b pour l'évaluation du risque de maladie cardiovasculaire
US11193947B2 (en) 2016-06-03 2021-12-07 Cedars-Sinai Medical Center B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment
EP3499230A4 (fr) * 2016-08-09 2020-07-29 Otsuka Pharmaceutical Co., Ltd. Procédé d'aide au diagnostic de la maladie d'alzheimer mettant en uvre un biomarqueur de l'urine
EP3665483A4 (fr) * 2017-08-08 2021-07-14 Queensland University of Technology Méthodes pour diagnostiquer les stades précoces de l'insuffisance cardiaque
US11255844B2 (en) * 2018-03-06 2022-02-22 Fresenius Medical Care Holdings, Inc. Peritoneal dialysis systems and related methods

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
JP2676114B2 (ja) * 1990-04-16 1997-11-12 塩野義製薬株式会社 ｈＢＮＰを認識するモノクローナル抗体および該抗体を用いるｈＢＮＰの免疫測定法
DK1698901T3 (da) * 1999-01-29 2008-12-08 Roche Diagnostics Gmbh Metode til at detektere N-terminalt proBNP
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
MXPA03004105A (es) * 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
GB0216191D0 (en) * 2002-07-11 2002-08-21 Univ Leicester Plasma urotensin in human heart failure
US8263325B2 (en) * 2002-11-15 2012-09-11 Ottawa Heart Institute Research Corporation Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis
US7109023B2 (en) * 2002-11-18 2006-09-19 Princeton Biomeditech Corporation Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
US20040265926A1 (en) * 2002-11-21 2004-12-30 Leong Ng Bodily fluid markers of tissue hypoxia
US7092759B2 (en) * 2003-07-30 2006-08-15 Medtronic, Inc. Method of optimizing cardiac resynchronization therapy using sensor signals of septal wall motion
US7887750B2 (en) * 2004-05-05 2011-02-15 Bayer Healthcare Llc Analytical systems, devices, and cartridges therefor
EP1722232A1 (fr) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Dispositifs et procédés de diagnostics ou de prévoir d'un stade précoce des dysfonctionnements cardiaques

Also Published As

Publication number Publication date
EP1880221A1 (fr) 2008-01-23
WO2006120152A1 (fr) 2006-11-16
ES2352351T3 (es) 2011-02-17
CN103091497A (zh) 2013-05-08
DE602006017058D1 (de) 2010-11-04
CA2605247A1 (fr) 2006-11-16
US20110104813A1 (en) 2011-05-05
EP1722232A1 (fr) 2006-11-15
EP1880221B1 (fr) 2010-09-22
JP4927825B2 (ja) 2012-05-09
JP2008541078A (ja) 2008-11-20
CN101171517B (zh) 2013-10-09
ATE482398T1 (de) 2010-10-15
CN101171517A (zh) 2008-04-30

Similar Documents

Publication Publication Date Title
HK1119771A1 (en) Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
EP2315034A3 (fr) Moyens et procédés d'évaluation du risque d'interventions cardiaques basées sur GDF-15
ATE545032T1 (de) Diagnose von herz-kreislauf-erkrankung
WO2007062090A3 (fr) Procedes et compositions lies a des analyses de lymphocytes b
WO2005071407A3 (fr) Methodes
WO2010025393A3 (fr) Marqueurs biologiques protéiques et méthodes pour diagnostiquer la maladie de kawasaki
WO2005118878A3 (fr) Methodes de criblage de proliferation cellulaire ou de troubles neoplasiques
EP2177908A3 (fr) Marqueurs associés au diabète et procédés d'utilisation de ceux-ci
EP1745287A4 (fr) Diagnostic et suivi de maladies inflammatoires par la mesure de composants du complement sur des leucocytes
WO2008061149A3 (fr) Procédés et compositions de diagnostic et de pronostic de la sténose d'artère rénale
EP1819827A4 (fr) Methodes de diagnostic et de traitement de la maladie de crohn
BRPI0410261A (pt) método de detecção de probnp natural
WO2007056523A3 (fr) Procedes de diagnostic et de surveillance de la progression d'un cancer
WO2009101059A3 (fr) Procédés d'utilisation d'antagonistes de la cadhérine 11 (cdh11)
DK1756571T3 (da) Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande
WO2005121362A3 (fr) Methode de quantification selective d'isoformes de vegf dans un echantillon biologique et ses utilisations
WO2008042826A3 (fr) Utilisation d'omentine1 et d'omentine pour le diagnostic et le traitement de maladies
WO2006002930A3 (fr) Polymorphisme fcgammariia et son utilisation dans un diagnostic
ATE473448T1 (de) Verfahren zur diagnose von herz-kreislauf- krankheiten
WO2008131261A3 (fr) Biomarqueurs peptidiques de maladie cardiovasculaire
WO2008080030A3 (fr) Panel de maladies auto-immunes cardiovasculaires et méthodes d'utilisation correspondantes
WO2005034737A3 (fr) Diagnostic et traitement de troubles du reticulum endoplasmique
ATE437182T1 (de) Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
WO2003068958A1 (fr) Procede d'analyse d'un acide nucleique specifiant un gene presentant une modification de son niveau d'expression liee a la schizophrenie